Article
Investigation of nuclear nano-morphology marker as a biomarker for cancer risk assessment using a mouse model.
Journal of biomedical optics - 1 Jun 2012
Bista Rajan K, Uttam Shikhar, Hartman Douglas J, Qiu Wei, Yu Jian, Zhang Lin, Brand Randall E, Liu Yang
Abstract excerpt
The development of accurate and clinically applicable tools to assess cancer risk is essential to define candidates to undergo screening for early-stage cancers at a curable stage or provide a novel method to monitor chemoprevention treatments. With the use of our recently developed optical technology--spatial-domain low-coherence quantitative phase microscopy (SL-QPM), we have derived a novel optical biomarker...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
